WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
1. (WO1995001326) ANTI-ATHEROSCLEROTIC DIARYL COMPOUNDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1995/001326    International Application No.:    PCT/GB1994/001409
Publication Date: 12.01.1995 International Filing Date: 29.06.1994
Chapter 2 Demand Filed:    25.08.1994    
IPC:
C07C 233/25 (2006.01), C07C 233/33 (2006.01), C07C 233/54 (2006.01), C07C 233/75 (2006.01), C07C 235/34 (2006.01), C07C 237/24 (2006.01), C07C 255/46 (2006.01), C07C 271/28 (2006.01), C07C 275/36 (2006.01), C07C 311/21 (2006.01), C07C 311/29 (2006.01), C07C 317/22 (2006.01), C07C 323/41 (2006.01), C07D 211/32 (2006.01), C07D 211/88 (2006.01), C07D 295/192 (2006.01), C07D 309/04 (2006.01), C07D 309/08 (2006.01), C07D 309/10 (2006.01), C07D 521/00 (2006.01)
Applicants: THE WELLCOME FOUNDATION LIMITED [GB/GB]; Unicorn House, 160 Euston Road, London NW1 2BP (GB) (For All Designated States Except US).
ARROWSMITH, Richard, James [GB/GB]; (GB) (For US Only).
DANN, John, Gordon [GB/GB]; (GB) (For US Only).
FRANZMANN, Karl, Witold [GB/GB]; (GB) (For US Only).
HODGSON, Simon, Teanby [GB/GB]; (GB) (For US Only).
WATES, Peter, John [GB/GB]; (GB) (For US Only)
Inventors: ARROWSMITH, Richard, James; (GB).
DANN, John, Gordon; (GB).
FRANZMANN, Karl, Witold; (GB).
HODGSON, Simon, Teanby; (GB).
WATES, Peter, John; (GB)
Agent: ROLLINS, Anthony, John; The Wellcome Foundation Limited, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB)
Priority Data:
9313459-1 30.06.1993 GB
9406005-0 25.03.1994 GB
Title (EN) ANTI-ATHEROSCLEROTIC DIARYL COMPOUNDS
(FR) COMPOSES DE DIARYLE CONTRE L'ATHEROSCLEROSE
Abstract: front page image
(EN)The present invention is concerned with diaryl compounds of formula (I) and their use in medical therapy, particularly in the prophylaxis or treatment of a clinical condition for which an ACAT inhibitor is indicated, such as hyperlipidaema or atherosclerosis. The invention also relates to pharmaceutical compositions and processes for the preparation of compounds according to the invention.
(FR)L'invention concerne des composés de diaryle représentés par la formule (I) et leur utilisation en thérapie médicale, notamment dans la prophylaxie ou le traitement d'un état clinique pour lequel un inhibiteur de ACAT est recommandé, tel que l'hyperlipidémie ou l'athérosclérose. L'invention concerne également des compositions pharmaceutiques et des procédés de préparation desdits composés.
Designated States: AU, CA, CN, CZ, FI, GE, HU, JP, KE, KR, KZ, LV, MW, NO, NZ, PL, RU, SD, SI, SK, UA, US, UZ.
European Patent Office (EPO) (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)